Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor, The Journal of Cell Biology, vol.105, issue.2, pp.949-956, 1987. ,
DOI : 10.1083/jcb.105.2.949
Regulation of myogenic differentiation by type beta transforming growth factor, The Journal of Cell Biology, vol.103, issue.5, pp.1799-1805, 1986. ,
DOI : 10.1083/jcb.103.5.1799
Maturation of the Myogenic Program Is Induced by Postmitotic Expression of Insulin-Like Growth Factor I, Molecular and Cellular Biology, vol.19, issue.4, pp.3115-3124, 1999. ,
DOI : 10.1128/MCB.19.4.3115
IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1, Nature, vol.400, issue.6744, pp.581-585, 1999. ,
Evidence for the involvement of interleukin 6 in experimental cancer cachexia., Journal of Clinical Investigation, vol.89, issue.5, pp.1681-1684, 1992. ,
DOI : 10.1172/JCI115767
Tumor necrosis factor inhibits human myogenesis in vitro., Molecular and Cellular Biology, vol.8, issue.6, pp.2295-2301, 1988. ,
DOI : 10.1128/MCB.8.6.2295
TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways, The EMBO Journal, vol.21, issue.4, pp.631-642, 2002. ,
DOI : 10.1093/emboj/21.4.631
NF-kappa B-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia, Science, vol.289, issue.5488, pp.2363-2365, 2000. ,
DOI : 10.1126/science.289.5488.2363
Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?, FEBS Journal, vol.302, issue.Suppl 2, pp.4131-4148, 2013. ,
DOI : 10.1111/febs.12338
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6, Physiological Reviews, vol.88, issue.4, pp.1379-1406, 2008. ,
DOI : 10.1152/physrev.90100.2007
p38 MAPK-induced Nuclear Factor-??B Activity Is Required for Skeletal Muscle Differentiation: Role of Interleukin-6, Molecular Biology of the Cell, vol.15, issue.4, pp.2013-2026, 2004. ,
DOI : 10.1091/mbc.E03-08-0585
Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway, AJP: Cell Physiology, vol.304, issue.2, pp.128-136, 2013. ,
DOI : 10.1152/ajpcell.00025.2012
Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy, Cell Metabolism, vol.7, issue.1, pp.33-44, 2008. ,
DOI : 10.1016/j.cmet.2007.11.011
Role of Interleukin-6 in Growth Failure: An Animal Model, Hormone Research in Paediatrics, vol.58, issue.1, pp.24-27, 2002. ,
DOI : 10.1159/000064757
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice, Diabetologia, vol.101, issue.Suppl 2, pp.1306-1316, 2008. ,
DOI : 10.1007/s00125-008-0998-8
IL-6-induced skeletal muscle atrophy, Journal of Applied Physiology, vol.98, issue.3, pp.911-917, 2005. ,
DOI : 10.1152/japplphysiol.01026.2004
Molecular mechanisms regulating myogenic determination and differentiation, Frontiers of Bioscience, vol.1, issue.5, pp.750-767, 2000. ,
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice, Cancer Research, vol.50, issue.8, pp.2290-2295, 1990. ,
Cellular and molecular mechanisms of muscle atrophy, Disease Models & Mechanisms, vol.6, issue.1, pp.25-39 ,
DOI : 10.1242/dmm.010389
Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1, Aging, vol.1, issue.5, pp.451-457, 2009. ,
DOI : 10.18632/aging.100050
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase, The EMBO Journal, vol.20, issue.16, pp.4370-4379, 2001. ,
DOI : 10.1093/emboj/20.16.4370
ROCK2 and Its Alternatively Spliced Isoform ROCK2m Positively Control the Maturation of the Myogenic Program, Molecular and Cellular Biology, vol.27, issue.17, pp.6163-6176, 2007. ,
DOI : 10.1128/MCB.01735-06
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase, Proceedings of the National Academy of Sciences, vol.101, issue.37, pp.13489-13494, 2004. ,
DOI : 10.1073/pnas.0405659101
Myostatin is a novel tumoral factor that induces cancer cachexia, Biochemical Journal, vol.117, issue.1, pp.23-36, 2012. ,
DOI : 10.1038/nrm3028
Cellular dynamics in the muscle satellite cell niche, EMBO Reports, vol.14, issue.12, pp.1062-1072, 2013. ,
IL-6/IL-6 receptor system and its role in physiological and pathological conditions, Clinical Science, vol.69, issue.4, pp.143-159, 2012. ,
DOI : 10.1038/clpt.2009.313
Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochemical Journal, vol.374, issue.1, pp.1-20, 2003. ,
DOI : 10.1042/bj20030407
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2, Genes & Development, vol.17, issue.>11, pp.1352-1365, 2003. ,
DOI : 10.1101/gad.1089403
Signaling in Muscle Atrophy and Hypertrophy, Physiology, vol.23, issue.3, pp.160-170, 2008. ,
DOI : 10.1152/physiol.00041.2007
CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice, International Journal of Cancer, vol.48, issue.4, pp.592-595, 2004. ,
DOI : 10.1002/ijc.20270
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview, Journal of Interferon & Cytokine Research, vol.29, issue.6, pp.313-325, 2009. ,
DOI : 10.1089/jir.2008.0027
Monocyte Chemotactic Protein-1 Is a Potential Player in the Negative Cross-Talk between Adipose Tissue and Skeletal Muscle, Endocrinology, vol.147, issue.5, pp.2458-2467, 2006. ,
DOI : 10.1210/en.2005-0969
Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia, Exercise and Sport Sciences Reviews, vol.38, issue.4, pp.168-176, 2010. ,
DOI : 10.1097/JES.0b013e3181f44f11